miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1

References

• Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171. doi: 10.1016/j.jhep.2018.09.014.
   PubMed Web of Science ®Google Scholar
• D’Amico G, Morabito A, D’Amico M, et al. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis. Hepatol Int. 2018;12(Suppl 1):34–43. doi: 10.1007/s12072-017-9808-z.
   PubMed Web of Science ®Google Scholar
• Sun B, Karin M. NF-kappaB signaling, liver disease and hepatoprotective agents. Oncogene. 2008;27(48):6228–6244. doi: 10.1038/onc.2008.300.
   PubMed Web of Science ®Google Scholar
• Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-beta: the master regulator of fibrosis. Nat Rev Nephrol. 2016;12(6):325–338. doi: 10.1038/nrneph.2016.48.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7(8):425–436. doi: 10.1038/nrgastro.2010.97.
   PubMed Web of Science ®Google Scholar
• Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64(5):830–841. doi: 10.1136/gutjnl-2014-306842.
   PubMed Web of Science ®Google Scholar
• Shi Y, Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell. 2003;113(6):685–700. doi: 10.1016/s0092-8674(03)00432-x.
   PubMed Web of Science ®Google Scholar
• Mullen AC, Wrana JL. TGF-beta family signaling in embryonic and somatic stem-cell renewal and differentiation. Cold Spring Harb Perspect Biol. 2017;9(7):a022186. doi: 10.1101/cshperspect.a022186.
   PubMed Web of Science ®Google Scholar
• Mederacke I, Hsu CC, Troeger JS, et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun. 2013;4:2823. doi: 10.1038/ncomms3823.
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan microRNAs. Cell. 2018;173(1):20–51. doi: 10.1016/j.cell.2018.03.006.
   PubMed Web of Science ®Google Scholar
• Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol. 2010;11(4):252–263. doi: 10.1038/nrm2868.
   PubMed Web of Science ®Google Scholar
• Suzuki HI. MicroRNA control of TGF-beta signaling. Int J Mol Sci. 2018;19(7):1901. doi: 10.3390/ijms19071901.
   Web of Science ®Google Scholar
• Chen W, Yan X, Yang A, et al. miRNA-150-5p promotes hepatic stellate cell proliferation and sensitizes hepatocyte apoptosis during liver fibrosis. Epigenomics. 2020;12(1):53–67. doi: 10.2217/epi-2019-0104.
   PubMed Web of Science ®Google Scholar
• Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–874. doi: 10.1038/nrg3074.
   PubMed Web of Science ®Google Scholar
• Othman N, Nagoor NH. The role of microRNAs in the regulation of apoptosis in lung cancer and its application in cancer treatment. Biomed Res Int. 2014;2014:318030. doi: 10.1155/2014/318030.
   PubMed Web of Science ®Google Scholar
• Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol. 2014;15(9):565–576. doi: 10.1038/nrm3854.
   PubMed Web of Science ®Google Scholar
• Kota J, Chivukula RR, O’Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137(6):1005–1017. doi: 10.1016/j.cell.2009.04.021.
   PubMed Web of Science ®Google Scholar
• Bowen T, Jenkins RH, Fraser DJ. MicroRNAs, transforming growth factor beta-1, and tissue fibrosis. J Pathol. 2013;229(2):274–285. doi: 10.1002/path.4119.
   PubMed Web of Science ®Google Scholar
• Fan Y, Chen H, Huang Z, et al. Emerging role of miRNAs in renal fibrosis. RNA Biol. 2020;17(1):1–12. doi: 10.1080/15476286.2019.1667215.
   PubMed Web of Science ®Google Scholar
• He Y, Huang C, Li J. miR-21 is a critical therapeutic target for renal fibrosis. Cell Biochem Biophys. 2014;68(3):635–636. doi: 10.1007/s12013-013-9745-y.
   PubMed Web of Science ®Google Scholar
• Yang S, Banerjee S, de Freitas A, et al. Participation of miR-200 in pulmonary fibrosis. Am J Pathol. 2012;180(2):484–493. doi: 10.1016/j.ajpath.2011.10.005.
   PubMed Web of Science ®Google Scholar
• Wang B, Komers R, Carew R, et al. Suppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol. 2012;23(2):252–265. doi: 10.1681/ASN.2011010055.
   PubMed Web of Science ®Google Scholar
• Yang H, Fang F, Chang R, et al. MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor beta receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology. 2013;58(1):205–217. doi: 10.1002/hep.26315.
   PubMed Web of Science ®Google Scholar
• Dewidar B, Meyer C, Dooley S, Nadja Meindl B. TGF-β in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8(11):1419. doi: 10.3390/cells8111419.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Liver fibrosis–from bench to bedside. J Hepatol. 2003;38:38–53. doi: 10.1016/S0168-8278(02)00429-4.
   PubMed Web of Science ®Google Scholar
• Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9(4):875. doi: 10.3390/cells9040875.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Matsuzaki K, Murata M, et al. Clinico-pathological importance of TGF-beta/Phospho-Smad signaling during human hepatic fibrocarcinogenesis. Cancers (Basel). 2018;10(6):183. doi: 10.3390/cancers10060183.
   PubMed Web of Science ®Google Scholar
• Li H, Yang R, Fan X, et al. MicroRNA array analysis of microRNAs related to systemic scleroderma. Rheumatol Int. 2012;32(2):307–313. doi: 10.1007/s00296-010-1615-y.
   PubMed Web of Science ®Google Scholar
• David CJ, Massagué J. Contextual determinants of TGFβ action in development, immunity and cancer. Nat Rev Mol Cell Biol. 2018;19(7):419–435. doi: 10.1038/s41580-018-0007-0.
   PubMed Web of Science ®Google Scholar
• Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007;117(3):539–548. doi: 10.1172/JCI30542.
   PubMed Web of Science ®Google Scholar
• Iwaisako K, Jiang C, Zhang M, et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci USA. 2014;111(32):E3297–E3305.
   PubMed Web of Science ®Google Scholar
• Miyazawa K, Shinozaki M, Hara T, et al. Two major Smad pathways in TGF-β superfamily signalling. Genes Cells. 2002;7(12):1191–1204. doi: 10.1046/j.1365-2443.2002.00599.x.
   PubMed Web of Science ®Google Scholar
• Liao W, Liang P, Liu B, et al. MicroRNA-140-5p mediates renal fibrosis through TGF-beta1/Smad signaling pathway by directly targeting TGFBR1. Front Physiol. 2020;11:1093. doi: 10.3389/fphys.2020.01093.
   PubMed Web of Science ®Google Scholar
• Tijsen AJ, van der Made I, van den Hoogenhof MM, et al. The microRNA-15 family inhibits the TGFbeta-pathway in the heart. Cardiovasc Res. 2014;104(1):61–71. doi: 10.1093/cvr/cvu184.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Shiok TC, Richards AM, et al. Treatment with miRNA-101a prevents sustained hypertension-induced cardiac fibrosis and loss of cardiac function via actions as an endogenous inhibitor of TGF-β signaling. Circulation. 2017;136(suppl_1):A15653-A.
   Google Scholar